ANTI CARDIOLIPIN IgM (In Pune)

The Anti-Cardiolipin IgM Test specifically measures the IgM class of antibodies that target cardiolipin in the body.

test
test
Report Availability
24 hours
₹ 850 /-
Free Home Blood Collection

Overview

The Anti-Cardiolipin IgM Test is a blood test used to detect the presence of IgM antibodies against cardiolipin, a phospholipid that is a crucial component of the cell membrane. These antibodies, known as anti-cardiolipin antibodies, are associated with various autoimmune disorders and can contribute to thrombosis (blood clot formation). The test is primarily used to help diagnose conditions like antiphospholipid syndrome (APS), which is a major cause of recurrent miscarriages, strokes, deep vein thrombosis (DVT), and other clotting disorders.

Why is the Anti-Cardiolipin IgM Test Important?

The Anti-Cardiolipin IgM Test is a valuable diagnostic tool in identifying autoimmune disorders, particularly antiphospholipid syndrome (APS), which is characterized by the presence of certain antibodies that cause blood clotting. This syndrome can result in serious health complications, especially if left undiagnosed and untreated.
1] Diagnosing Antiphospholipid Syndrome (APS): APS is a condition in which the immune system produces autoantibodies that attack the body's phospholipids, leading to increased clot formation. This test helps in the diagnosis of APS, which is a leading cause of recurrent miscarriages, stroke, and venous or arterial thrombosis.
2] Evaluating Pregnancy Complications: Women with high levels of anti-cardiolipin IgM antibodies are at a higher risk of experiencing pregnancy complications, such as recurrent miscarriages or preterm birth. The test is often performed in pregnant women who have experienced multiple pregnancy losses or who are at risk for thrombotic events.
3] Assessing Risk of Thrombosis: Elevated levels of anti-cardiolipin IgM antibodies indicate an increased risk of developing blood clots in the veins or arteries. This can lead to deep vein thrombosis (DVT), pulmonary embolism, or stroke. The test is used to assess individuals with unexplained clotting events or those with a family history of thrombotic disorders.
4] Monitoring Autoimmune Disorders: The test is also helpful in monitoring autoimmune diseases like lupus (systemic lupus erythematosus), as individuals with lupus often test positive for anti-cardiolipin antibodies. It can provide insight into disease activity and help guide treatment decisions.

How is the Anti-Cardiolipin IgM Test Performed?

The Anti-Cardiolipin IgM Test is a relatively simple blood test that requires a sample of venous blood, typically drawn from a vein in the arm. The procedure is performed in a laboratory setting, and the blood sample is analyzed to measure the concentration of anti-cardiolipin IgM antibodies.
1] Anti-Cardiolipin IgG Test: This test measures the IgG class of antibodies and can provide additional information about the presence of antiphospholipid antibodies in the body.
2] Lupus Anticoagulant (LA) Test: This is another test that assesses the presence of lupus anticoagulants, which are commonly seen in patients with antiphospholipid syndrome.
The results of the Anti-Cardiolipin IgM Test are usually reported as positive or negative, along with a quantitative value that measures the concentration of antibodies in the blood. The presence of a high concentration of anti-cardiolipin IgM antibodies suggests the need for further testing and may require clinical intervention.

Interpreting the Results

1] Positive Results: A positive result indicates the presence of anti-cardiolipin IgM antibodies in the blood. This can suggest the presence of antiphospholipid syndrome (APS), especially if the result is confirmed with other tests like anti-cardiolipin IgG or the lupus anticoagulant test. Positive results can also suggest an increased risk of clotting events, recurrent miscarriage, or pregnancy complications.
2] Negative Results: A negative result typically means that anti-cardiolipin IgM antibodies are not present in significant amounts. However, it's important to note that the absence of these antibodies does not completely rule out the possibility of APS or other autoimmune conditions, and additional testing may be needed.

Why Choose Diagnopein for ANTI CARDIOLIPIN IgM Test?

At Diagnopein, we offer comprehensive, accurate, and timely diagnostic services, including the Anti Cardiolipin IgM Test Pune. With our NABL-accredited labs, cutting-edge technology, and skilled technicians, you can be assured of reliable results every time. Get your results quickly, especially when time is crucial in detecting severe infections.

Competitive pricing without compromising on quality. Our team of experienced professionals ensures the test is conducted smoothly with minimal discomfort. We provide not just the Anti Cardiolipin IgM Test results but insights into your health condition, helping you and your doctor make informed decisions about treatment. For more information call us at +91 9204 108108.

Talk to an Pathologist

  I HereBy Consent to receive calls/messagess from Diagnopein Pathology and its partners and override DND settings

faq image

Frequently Asked Questions

There is no special preparation required for the Anti-Cardiolipin IgM Test. However, it’s important to inform your doctor about any medications you are taking, as certain medications might affect antibody levels or test accuracy.

The test involves a routine blood draw, so risks are minimal but may include mild discomfort, bruising, or infection at the site of the needle insertion. The procedure is generally considered safe.

The test involves a blood draw from a vein, typically in the arm. The sample is sent to a laboratory where it is analyzed for the presence of IgM antibodies against cardiolipin. The results are typically reported as positive or negative, with quantitative measurements indicating the concentration of antibodies.

The test is performed to diagnose antiphospholipid syndrome (APS), monitor pregnancy complications like recurrent miscarriage, and assess the risk of thrombosis (blood clots) in individuals with autoimmune diseases like lupus. It helps detect abnormal autoantibodies that interfere with normal blood clotting.